|
TW499412B
(en)
|
1996-11-26 |
2002-08-21 |
Dimensional Pharm Inc |
Aminoguanidines and alkoxyguanidines as protease inhibitors
|
|
EP1036063B1
(en)
|
1997-11-26 |
2006-11-02 |
Ortho-McNeil Pharmaceuticals, Inc. |
Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
|
|
US6344486B1
(en)
*
|
1998-04-03 |
2002-02-05 |
3-Dimensional Pharmaceuticals, Inc. |
Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
|
|
US6417161B1
(en)
|
1998-04-24 |
2002-07-09 |
3-Dimensional Pharmaceuticals, Inc. |
Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
|
|
EA004884B1
(ru)
|
1998-06-11 |
2004-08-26 |
3-Дименшенл Фамэсьютикэлс, Инк. |
Соединения пиразинона, фармацевтическая композиция (варианты) и лекарственная форма, способ ингибирования сериновой протеазы, способ снижения тромбообразующей способности поверхности, способ лечения нарушенного протеолиза и тромбоза, связанного с различными заболеваниями, способ снижения свертывания крови у млекопитающего
|
|
FR2786181B1
(fr)
*
|
1998-11-24 |
2001-10-26 |
Hoechst Marion Roussel Inc |
Nouveaux derives d'iminoguanidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
|
|
AU2381600A
(en)
|
1998-12-23 |
2000-07-31 |
Du Pont Pharmaceuticals Company |
Thrombin or factor xa inhibitors
|
|
EP1194428B1
(en)
|
1999-07-09 |
2003-09-17 |
3-Dimensional Pharmaceuticals, Inc. |
Heteroaryl protease inhibitors and diagnostic imaging agents
|
|
DE60006407T2
(de)
|
1999-09-13 |
2004-09-09 |
3-Dimensional Pharmaceuticals, Inc. |
Azazykloalkanone serin-protease-hemmer
|
|
US6476016B2
(en)
|
2000-07-17 |
2002-11-05 |
3-Dimensional Pharmaceuticals, Inc. |
Cyclic oxyguanidine pyrazinones as protease inhibitors
|
|
CA2417914A1
(en)
|
2000-08-04 |
2002-02-14 |
3-Dimensional Pharmaceuticals, Inc. |
Cyclic oxyguanidine protease inhibitors
|
|
US6486174B2
(en)
|
2000-08-07 |
2002-11-26 |
3-Dimensional Pharmaceuticals, Inc. |
Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
|
|
US6589504B1
(en)
|
2000-09-22 |
2003-07-08 |
Pharmacia & Upjohn Company |
Compounds and methods for diagnosing and treating amyloid-related conditions
|
|
DK1383756T3
(da)
*
|
2001-04-24 |
2008-06-23 |
Aryx Therapeutics |
Cumarinderivater til anvendelse som antikoagulanter
|
|
BR0213824A
(pt)
|
2001-11-06 |
2004-08-31 |
Wyeth Corp |
Processo para a preparação de cloretos de 2-[alquil(aril)] sulfonilbenzenossulfonila e dos seus intermediários
|
|
AU2003302238A1
(en)
|
2002-12-03 |
2004-06-23 |
Axys Pharmaceuticals, Inc. |
2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
|
|
US20050014786A1
(en)
*
|
2003-07-11 |
2005-01-20 |
Chongqing Sun |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
|
GB0507577D0
(en)
*
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
US20070086958A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Medafor, Incorporated |
Formation of medically useful gels comprising microporous particles and methods of use
|
|
US20070087061A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Medafor, Incorporated |
Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
|
|
PT2724722T
(pt)
|
2006-10-20 |
2017-03-14 |
Neurendo Pharma Llc |
Método de restaurar o efeito incretina
|
|
RU2354647C2
(ru)
*
|
2007-06-28 |
2009-05-10 |
Общество С Ограниченной Ответственностью "Бионика" |
Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе
|
|
RU2353619C2
(ru)
*
|
2007-06-28 |
2009-04-27 |
Общество С Ограниченной Ответственностью "Бионика" |
Новые соединения, обладающие функцией антикоагулянтов, фармацевтические композиции на их основе для лечения тромботических состояний и плазмозамещающий раствор для коррекции гиперкоагуляционных нарушений при гемодилюции
|
|
GB0815784D0
(en)
*
|
2008-08-29 |
2008-10-08 |
Xention Ltd |
Novel potassium channel blockers
|
|
CA2824599C
(en)
*
|
2010-12-31 |
2020-03-10 |
Corridor Pharmaceuticals, Inc. |
Arginase inhibitors and methods of use thereof
|
|
WO2015171558A2
(en)
*
|
2014-05-05 |
2015-11-12 |
Lycera Corporation |
BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
|
|
EP3215154B1
(en)
|
2014-11-07 |
2020-01-29 |
Regents of the University of Minnesota |
Salts and compositions useful for treating disease
|
|
CN110407721A
(zh)
*
|
2019-08-13 |
2019-11-05 |
上海毕得医药科技有限公司 |
一种4-氰基-3-(三氟甲基)苯-1-磺酰氯的合成方法
|